Clinical Evidence Reveals Key Differences Between Treatments
What's Better Mounjaro or Wegovy? Understanding UK Weight Loss Results
When comparing Mounjaro versus Wegovy for weight loss results in the UK, the evidence reveals two distinct approaches to weight management. Wegovy (semaglutide) demonstrated remarkable consistency across the STEP trial programme, with participants achieving approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions. Mounjaro (tirzepatide) operates through a dual-action mechanism targeting both GIP and GLP-1 receptors, representing a newer approach to weight management therapy. The question of what's better between Mounjaro or Wegovy ultimately depends on individual patient factors, medical history, and prescriber guidance.
Both treatments are licensed as prescription-only medicines in the UK and require ongoing commitment to reduced-calorie diet and increased physical activity. Clinical trials for each medication used different study designs and participant populations, making direct comparison of percentage weight loss results inappropriate. Instead, patients should focus on the underlying mechanisms, storage requirements, and dosing schedules when considering what's better between Mounjaro or Wegovy for their specific circumstances.
Wegovy Pricing and Value: Complete UK Cost Breakdown
Understanding the true cost of Wegovy helps clarify whether it's better than Mounjaro for your budget and treatment goals. Single pen prices start at £79.99 for the 0.25mg starter dose (weeks 1-4), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenient dose progression, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, while the Progress Trio (0.5mg, 1mg & 1.7mg) costs £369.99 for three months' supply. New customers apply discount code FIRST40 at checkout, while returning customers use DOSE25.
The Ultimate Stability Trio provides three 2.4mg maintenance pens for £649.99, offering consistency for established patients who've determined Wegovy is better than Mounjaro for their needs. Bundle pricing emphasises convenience rather than savings, ensuring Reliable Supply continuity and reducing ordering frequency. When weighing what's better between Mounjaro or Wegovy, consider that Wegovy's established presence in the UK market provides pricing stability and consistent availability through our GPhC-registered pharmacy.
STEP Trial Evidence: What Clinical Data Reveals About Wegovy
The landmark STEP clinical trial programme provides robust evidence for patients questioning what's better between Mounjaro or Wegovy. In STEP 1, participants taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 3 demonstrated even higher results of approximately 16% when combined with intensive behavioural therapy.
Long-term data from STEP 5 showed sustained weight loss of approximately 15.2% at two years, while the SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events. These results help inform the decision of what's better between Mounjaro or Wegovy, though patients should remember that individual results may vary and depend on adherence to lifestyle modifications prescribed alongside treatment.
How Wegovy Works: The Science Behind GLP-1 Weight Management
Understanding Wegovy's mechanism helps explain why some patients find it better than Mounjaro for their weight loss goals. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in the intestines after eating. This medication works on brain appetite centres, particularly in the hypothalamus, to reduce hunger signals and promote earlier satiety after smaller meals. The once-weekly FlexTouch injection provides consistent hormone levels, helping patients feel satisfied with reduced caloric intake throughout the week. Additionally, Wegovy may reduce food cravings and the reward associated with high-calorie foods, supporting long-term dietary changes. This focused GLP-1 approach has been extensively studied over many years, providing substantial safety and efficacy data for prescribers and patients considering whether Wegovy is better than Mounjaro.
Ordering Process: From Assessment to Next-Day Delivery
Determining what's better between Mounjaro or Wegovy starts with our streamlined ordering process designed for busy UK patients. The 3-minute online clinical assessment covers medical history, current medications, and weight management goals, helping prescribers evaluate suitability for either treatment. Standard prescriber review takes 3 working days, though express 24-hour review is available for urgent cases. Once approved, next-day delivery ensures your chosen medication arrives via temperature-controlled cold-chain logistics, maintaining the pharmaceutical integrity essential for injection treatments. Our GPhC-registered pharmacy team (#9012878) handles all aspects from clinical review to delivery coordination. Whether you've decided Wegovy is better than Mounjaro or need prescriber guidance on this decision, the entire process prioritises convenience and clinical safety.
Storage and Practical Considerations: Wegovy's Travel Advantage
Practical storage requirements often influence patients deciding what's better between Mounjaro or Wegovy for their lifestyle. Wegovy pens require refrigeration at 2-8°C before first use but offer significant travel flexibility with 6 weeks' room temperature tolerance below 30°C once removed from the fridge. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly suitable for frequent travellers or those with unpredictable schedules. The FlexTouch pen system provides reliable dose delivery with clear visual confirmation, while the mandatory dose escalation schedule (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) allows gradual tolerance building over 16 weeks. Each pen contains four weekly doses, and the prescription-only medicine status ensures proper medical supervision throughout treatment. Patients often find this structured progression helpful when evaluating whether Wegovy is better than Mounjaro for building sustainable weight management habits.
UK-Specific Weight Loss Evidence: Real-World Wegovy Results
Beyond asking what's better between Mounjaro or Wegovy, UK patients want evidence relevant to their healthcare system and population. Wegovy received NICE recommendation TA875 for weight management when prescribed alongside specialist support, reflecting confidence in its clinical value within the NHS framework. The MHRA's licensing covers adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities, aligning with UK obesity treatment guidelines. Real-world evidence from UK prescribing shows that patients who maintain treatment alongside lifestyle changes can achieve clinically meaningful weight loss comparable to trial results.
The recent MHRA approval of 7.2mg Wegovy (January 2026) demonstrates ongoing development, though this higher dose isn't yet available through EverydayMeds. When considering what's better between Mounjaro or Wegovy, UK patients benefit from Wegovy's established presence in British healthcare, comprehensive prescriber familiarity, and integration with existing weight management pathways. This infrastructure support can be crucial for long-term success regardless of which medication proves most suitable.
Making Your Decision: Wegovy Access Through EverydayMeds
Rather than definitively answering what's better between Mounjaro or Wegovy, we recognise that both treatments represent significant advances in weight management medicine. Both medications are available through our GPhC-registered online pharmacy, and your prescriber can help determine which aligns best with your medical history, lifestyle, and treatment goals. New customers use discount code FIRST40 at checkout, while returning customers apply DOSE25 for optimised pricing. The clinical assessment process considers your individual circumstances, ensuring whichever treatment you receive has the best chance of success. Our expert pharmacy team provides ongoing support throughout your weight management journey, whether that involves Wegovy, Mounjaro, or transitioning between treatments as your needs evolve. Start your assessment today through our secure platform, knowing that both options represent evidence-based approaches to sustainable weight loss.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
